Dr. Ned Sharpless in his role of Acting Commissioner of the United States Food & Drug Administration has inspected international mail facilities this past week.
In its efforts to fight the introduction into black market counterfeit vapor products and other dangerous substances into the U.S., the FDA pursues interdiction efforts at international mail centers. Smugglers of everything from fentanyl to counterfeit JUUL pods reportedly prefer international mail and parcel shipping staffing shortages promise better odds that their shipments will get through.
Sharpless noted this in a statement to CNBC on Tuesday:
“It is truly remarkable to have witnessed the stunning volume of parcels that come into a single international mail facility on any given day. Many of these parcels lack any package labeling, contain products labeled as dietary supplements with hidden drug ingredients, or contain drug products or medical devices that are unapproved or counterfeit.”
Sharpless went on to praise staff, saying:
“I commend the hard-working men and women who play a pivotal role working around the country in support of our essential mission to protect the health of the American people.”
Based on seizures so far, U.S. officials believe that China is the primary source of dangerous counterfeit vapor products. Stopping the flow of these counterfeits should be a priority for public safety. The FDA’s efforts on this point are a welcome reassurance that the agency enforces its consumer protection mission with focus and vigor.